Kazumichi Kawakubo

15PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 28, 2026
High CD73 Expression Is Associated with Poor Prognosis in Biliary Tract Cancer Through Reduced Stromal Tumor-Infiltrating Lymphocytes.

Shoya Shiratori, Kazumichi Kawakubo, Kanako C Hatanaka

|Mar 12, 2026
Effect of Skeletal Muscle Mass Loss on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasm.

Soichiro Oda, Kazumichi Kawakubo, Ryo Takagi

|Dec 30, 2025
DNMT3B Knockdown Enhances PARP Inhibitor Sensitivity in Biliary Tract Cancer Cells via Opioid Growth Factor Receptor-Mediated Homologous Recombination Impairment.

Soichiro Oda, Kazumichi Kawakubo, Masaki Kuwatani

|Jul 21, 2025
Hepatocellular carcinoma with recurrent pancreatic metastasis 17 years after radical resection.

Soichiro Oda, Kazumichi Kawakubo, Shoya Shiratori

|Sep 09, 2023
Metabolomics of Duodenal Juice for Biliary Tract Cancer Diagnosis.

Kazuma Kishi, Masaki Kuwatani, Yuki Ohnishi

|Sep 17, 2022
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.

Kazumichi Kawakubo, Carlos Fernández-Del Castillo, Andrew Scott Liss

Pageof 3

Frequent Collaborators

7 joint publications

Masaki Kuwatani

5 joint publications

Ryo Sugiura

2 joint publications

Shin Kato

2 joint publications

Hiroyuki Isayama